D. E. Shaw & Co., Inc. - SYNAGEVA BIOPHARMA CORP ownership

Quarter-by-quarter ownership
D. E. Shaw & Co., Inc. ownership history of SYNAGEVA BIOPHARMA CORP
ValueSharesWeighting
Q1 2015$6,857,000
+328.0%
70,303
+201.9%
0.01%
+450.0%
Q3 2014$1,602,000
-34.7%
23,289
-0.5%
0.00%
-33.3%
Q2 2014$2,454,000
-63.1%
23,414
-70.8%
0.00%
-66.7%
Q1 2014$6,645,00080,0840.01%
Other shareholders
SYNAGEVA BIOPHARMA CORP shareholders Q3 2023
NameSharesValueWeighting ↓
Baker Brothers Advisors 10,660,432$989,182,00010.10%
BB BIOTECH AG 1,130,476$104,897,0003.40%
BLUE JAY CAPITAL MANAGEMENT, LLC 80,000$7,423,0003.31%
Opus Point Partners Management, LLC 20,002$1,856,0001.84%
COLUMBIA WANGER ASSET MANAGEMENT LLC 3,847,094$356,972,0001.77%
SECTORAL ASSET MANAGEMENT INC 363,884$33,765,0001.52%
Cormorant Asset Management, LP 100,000$9,279,0001.43%
Tekla Capital Management LLC 223,020$20,694,0000.97%
Lamond Capital Partners LLC 15,390$1,428,0000.94%
Squarepoint Ops LLC 6,700$622,0000.60%
View complete list of SYNAGEVA BIOPHARMA CORP shareholders